Standout Papers

Efficacy of Pamidronate in Reducing Skeletal Events in Patients with Advanced Multiple Myeloma... 1996 2026 2006 2016 760
  1. Efficacy of Pamidronate in Reducing Skeletal Events in Patients with Advanced Multiple Myeloma (1996)
    James R. Berenson, Alan Lichtenstein et al. New England Journal of Medicine

Citation Impact

1 by Nobel laureates 4 from Science/Nature 78 standout
Sub-graph 1 of 19

Citing Papers

Daratumumab, Bortezomib, and Dexamethasone for Multiple Myeloma
2016 Standout
The Myeloma Drug Lenalidomide Promotes the Cereblon-Dependent Destruction of Ikaros Proteins
2013 StandoutScienceNobel
3 intermediate papers

Works of Oscar Ballester being referenced

Long-term pamidronate treatment of advanced multiple myeloma patients reduces skeletal events. Myeloma Aredia Study Group.
1998
Efficacy of Pamidronate in Reducing Skeletal Events in Patients with Advanced Multiple Myeloma
1996 Standout

Author Peers

Author Hematology Oncology Genetics RNMI Last Decade Papers Cites
Oscar Ballester 772 1247 161 353 42 1.8k
K. Rebecca Fega 69 35 13 1 6 349
O Cecconi 181 185 33 112 11 1.3k
Matthew Hartley 7 230
Vyvyan T. Coombe 37 1 8 366
Gerhard Goos 1 5 18 101 3.3k

All Works

Loading papers...

Rankless by CCL
2026